BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37446613)

  • 1. The Finally Rewarding Search for A Cytotoxic Isosteviol Derivative.
    Heisig J; Heise NV; Hoenke S; Ströhl D; Csuk R
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhodamine 101 Conjugates of Triterpenoic Amides Are of Comparable Cytotoxicity as Their Rhodamine B Analogs.
    Heise NV; Major D; Hoenke S; Kozubek M; Serbian I; Csuk R
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing an Amide-Spacered Triterpenoid Rhodamine Hybrid of Nano-Molar Cytotoxicity Combined with Excellent Tumor Cell/Non-Tumor Cell Selectivity.
    Heise NV; Denner TC; Becker S; Hoenke S; Csuk R
    Molecules; 2023 Sep; 28(17):. PubMed ID: 37687233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitocanic Di- and Triterpenoid Rhodamine B Conjugates.
    Hoenke S; Serbian I; Deigner HP; Csuk R
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cytotoxicity of the conjugates of diterpenoid isosteviol and
    Garifullin BF; Strobykina IY; Khabibulina LR; Sapunova AS; Voloshina AD; Sharipova RR; Khairutdinov BI; Zuev YF; Kataev VE
    Nat Prod Res; 2021 Apr; 35(8):1372-1378. PubMed ID: 31402704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the stevioside analogues of steviolbioside, steviol, and isosteviol 19-alkyl amide dimers: synthesis and cytotoxic and antibacterial activity.
    Lin LH; Lee LW; Sheu SY; Lin PY
    Chem Pharm Bull (Tokyo); 2004 Sep; 52(9):1117-22. PubMed ID: 15340201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation.
    Zhang T; Lu LH; Liu H; Wang JW; Wang RX; Zhang YX; Tao JC
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5827-32. PubMed ID: 22901386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homopiperazine-rhodamine B adducts of triterpenoic acids are strong mitocans.
    Wolfram RK; Fischer L; Kluge R; Ströhl D; Al-Harrasi A; Csuk R
    Eur J Med Chem; 2018 Jul; 155():869-879. PubMed ID: 29960206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
    Sommerwerk S; Heller L; Kerzig C; Kramell AE; Csuk R
    Eur J Med Chem; 2017 Feb; 127():1-9. PubMed ID: 28033541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anticancer evaluation of complex unsaturated isosteviol-derived triazole conjugates.
    Khaybullin RN; Liang X; Cisneros K; Qi X
    Future Med Chem; 2015; 7(18):2419-28. PubMed ID: 26653151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Madecassic Acid-A New Scaffold for Highly Cytotoxic Agents.
    Kraft O; Hartmann AK; Hoenke S; Serbian I; Csuk R
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, cytotoxic activity, and 2D- and 3D-QSAR studies of 19-carboxyl-modified novel isosteviol derivatives as potential anticancer agents.
    Liu CJ; Zhang T; Yu SL; Dai XJ; Wu Y; Tao JC
    Chem Biol Drug Des; 2017 Jun; 89(6):870-887. PubMed ID: 27878967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic and apoptosis-inducing activities of steviol and isosteviol derivatives against human cancer cell lines.
    Ukiya M; Sawada S; Kikuchi T; Kushi Y; Fukatsu M; Akihisa T
    Chem Biodivers; 2013 Feb; 10(2):177-88. PubMed ID: 23418165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of isosteviol triazole conjugates for cancer therapy.
    Khaybullin RN; Zhang M; Fu J; Liang X; Li T; Katritzky AR; Okunieff P; Qi X
    Molecules; 2014 Nov; 19(11):18676-89. PubMed ID: 25405286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asiatic acid as a leading structure for derivatives combining sub-nanomolar cytotoxicity, high selectivity, and the ability to overcome drug resistance in human preclinical tumor models.
    Kraft O; Hartmann AK; Brandt S; Hoenke S; Heise NV; Csuk R; Mueller T
    Eur J Med Chem; 2023 Mar; 250():115189. PubMed ID: 36780832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and cytotoxic activity of nitric oxide-releasing isosteviol derivatives.
    Wang TT; Liu Y; Chen L
    Bioorg Med Chem Lett; 2014 May; 24(9):2202-5. PubMed ID: 24685545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
    Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
    Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cytotoxic activity of MOM-ether analogs of isosteviol.
    Malki A; Laha R; Bergmeier SC
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1184-7. PubMed ID: 24444475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diterpenoid lead stevioside and its hydrolysis products steviol and isosteviol: Biological activity and structural modification.
    Wang M; Li H; Xu F; Gao X; Li J; Xu S; Zhang D; Wu X; Xu J; Hua H; Li D
    Eur J Med Chem; 2018 Aug; 156():885-906. PubMed ID: 30059803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F16 Hybrids Derived from Steviol or Isosteviol Are Accumulated in the Mitochondria of Tumor Cells and Overcome Drug Resistance.
    Heise NV; Heisig J; Meier K; Csuk R; Mueller T
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.